Crossmark

Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy

Published Online: 2016-07-18

Published Print: 2017-02-02

Authors

Michelle Xu, M

Pu, Y

Weichselbaum, R R

Fu, Y-X
License Information

Text and Data Mining valid from 2016-07-18

Version of Record valid from 2016-07-18
More Information

Article History

Received: 12 January 2016

Revised: 17 April 2016

Accepted: 28 April 2016

First Online: 18 July 2016

Competing interests

: The authors declare no conflict of interest.

Document is current